Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeppers...
The release of June sales figures follows the company’s recent launch of DischargeRX, a new program designed to increase and improve engagement between patients and hospitals. The company also made other major announcements during the month of June including the installation of a TCGRx Automated Pouch Packaging System at its Miami-Dade County PharmCo location; and the launch of a campaign designed to educate patients and providers on treatment alternatives to opioids.
RXMD
Net Revenue: $10,177,345 Estimate based on 1st Quarter Results, and Press Releases since.
340B Revenues: $2,900,000 Estimate based on Press Releases
Scripts Totals: 132,100
Yep...
RXMD getting better and better...
18.75% increase in prescriptions filled over the same month last year!
Thanks Five:
If it gets bought out, we're rich.
RXMD is stirring the pharmacy hornet's nest in FLA-USA right now... Stealing customers & market share, reinventing customer/patient relationships. Don't think the big dogs don't notice. That 3rd location will sound the alarms. Even large grocery chains like Publix will be taking notice.
We've just got to hang tough and keep the faith. Ms.Mars is as good as they come... She'll get us to the promised land with compounded earnings. Watch!
There is a lesser need to dilute shares as much when you're making a heaps of cash.
Nice Buy my friend...
Q2 will start the new Green Wave for RXMD...
Could be today, tomorrow but definitely this week...
Howz it looking Maz..?
OS gotta be way down by now yes..?
Q2 will start the new Green Wave for RXMD...
Could be today, tomorrow but definitely this week...
Agreed Silver...
RNVA will be returning to .03+ very soon!! Longs will be greatly rewarded. Those who have had the patience to stick around during this down time and not give into the nay sayers will become wealthy. I’m very excited for what the future holds! Good luck to all!
Yep...
The tide is turning up day by ever-loving day...
Deadjim $3.42 million quarterly NET PROFIT revenues is pretty dammed impressive for a stock trading this low and remember that reflects revenues for only 1 month of that quarter from the Jamestown hospital acquisition. Moving into the next quarter the CEO anticipates IN EXCESS OF 2 MIL NET REVENUES PER MONTH.
A lot of toxic debt has already been paid by shareholders through dilution. We are seeing REAL PROFITS HERE. That changes the landscape entirely and big buyers are sure to sit up and take notice especially AT THESE EXTREMELY LOW SHARE PRICES. You will start seeing RNVA trending up on solid gains once the 10Q comes out. Prior to that expect to see short term flipping although flippers impact will eventually become marginalized since they will have to rebuy in at a higher and higher PPS.
You are seeing a real turnaround. Something that almost never occurs in OTC. Enjoy the future ride because I am sure that there are many who will
Agreed Jerry...
Looks like we're washing away alot of the fliptards too...
$ RNVA. Yes its the very begining of the turn around back North and the CEO already sees that they can make these hospitals very profitable and want to add more hospitals in the same area which will help cutting operating cost even more to turn more profits. Buying out these hospitals at the beat down prices is the smart way to go and CEO Seamus Lagan & the New CFO learned that through thier Solutions part that they did from thier Fla operation in the past 2 are 3 years and now fixing to apply it to thier own hospitals and its already starting to pay off as shown in todays News.
GO > $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ RNVA
Just the start of something good... Really Good...
$ RNVA. RENNOVA HEALTH GIVES UPDATE ON SECOND QUARTER
WEST PALM BEACH, Fla, July 12, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired its second rural hospital in Tennessee on June 1, 2018, announces that its second quarter revenue has shown significant growth.
Rennova is pleased to announce preliminary second quarter net revenues of approximately $3.42 million. This number remains subject to final review and potential adjustment. This represents an increase of approximately $1.82 million from the reported net revenues from the first quarter and includes the first month from Rennova’s second hospital which it acquired on June 1, 2018. The Company continues to take a conservative position on revenue recognition in hospital operations and will maintain this position until we have adequate historical months to evidence total collection rates.
The acquired hospital, Jamestown TN Medical Center, received confirmation from the Centers for Medicare and Medicaid Services on June 29, that they had processed and approved the Change of Ownership and Provider Tie-in process. Billing has now started and the Company believes it will receive its first collections in a matter of weeks.
“We are pleased to have our second hospital starting to add to revenues and look forward to receipt of our first payments for services provided,” said Seamus Lagan, CEO of Rennova. “We remain confident that our two hospitals will be profitable and contribute in excess of $2 million a month to sales revenue in full operation and we look forward to exploring other opportunities for expansion of revenues or acquisition in the same geographic location.”
Rennova is also pleased to announce that it has ordered a new 64 slice CT scanner for its Oneida based hospital. The new state of the art, high resolution machine should be installed and in operation before the end of July. This addition will replace the existing aged machine and increase the services that can be offered to the communities served and to local physicians that currently send patients to other hospitals for high resolution scans. The Company expects this investment to immediately create increased revenues.
“We look forward to a significant improvement in the revenues and performance in Rennova in the coming quarters,” said Marlene McLennan, the recently appointed CFO of Rennova. “We expect to file our second quarter financial report to June 30 on time by August 14 and are making every effort to have it completed and filed earlier if possible”. https://investorshub.advfn.com/uimage/uploads/2018/7/5/ixotpRNVA_South_fork_hospital.jpg
https://investorshub.advfn.com/uimage/uploads/2018/7/5/zyirhRNVA_Jamestown_hospital.jpg
GO > $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ RNVA
Right Jimmy...
We're expecting the Q2 report this week yes..?
Should move it up for another Green Day in RXMD.
@PharmcoRX Twitter post. Check it out! Getting Noticed.
Our article on the DischargeRX program was picked up by Pharmaceutical Technology today. Please check it out and share
https://t.co/HplG1nC6cm
http://www.pharmtech.com/new-program-aims-improve-patient-medication-adherence-0?utm_source=hootsuite&utm_medium=hootsuite&utm_term=hootsuite&utm_content=hootsuite&utm_campaign=hootsuite
Yep and if someone hits the ask with a few shares we're up 50% again...
Keep up the Ask Smacking till it holds up for good...
Best is yet to Be...
Same here my friend...
Best days still yet to come...
Time is on our side...
Then all will know the meaning of "RXMD GOLD..!"
I have been averaging down...day by day, week by week.
I am sure it will go back up soon.
Just the other way around...
The Golden Period is still ahead for RXMD not behind us now...
When Q2 comes out we will see some of that Gold...
Now, do I have to slap the Ask to get this back up to 7 ..?
Come on people...
Buying small increments at the Ask can do wonders...
Then be sure to lock them up..!
I truly enjoy your posts Bids...
When might we get the next update on current OS..?
91 million plus shares today, 260 plus trades indicates by the number of transactions and the spread that MMs are making profits off the spreads. The name of the game for MMs is always generating profits. Not surprising then to see MMs keeping the price down to keep volume up to maximize profits on spreads. Most of the MM spreads today averaged 8% to 9% returns.
Makes them money at retails expense. Expect to see more of the same as sideways movement will probably continue until retail volume dries up. MMs will then either drop PPS to entice an increase in retail activity or buy enough shares to entice flipping.
Unfortunately the ability of RNVA to generate future revenues has no real impact on PPS at this point in time. Its entirely the MMs game to play until RNVA has real profitability showing in its 10Q/10K unless some very significant news attracts bigger money.
With the large number of shares in the float there are plenty of shares to be flipped at some level. While this works marginally for flippers there are still unknown holding periods and minimal profits to be made due to increased competition.
The only thing that will really cause this stock to uptrend is going to be real performance. So many shares out at such low pricing will mostly encourage flipping which marginally helps liquidity but minimizes any real upside.
The upcoming 10Q will have better numbers for a bunch of reasons. One is simply because one month of the Jamestown hospital as well as 3 months of the Oneida hospital revenue stream is starting to kick in although I am not sure how exactly how revenues will show from the Jamestown hospital other than as a receivable on the books since RNVA only recently received State approval to allow them to retroactive bill for services provided at Jamestown since June 1, 2018. The bigger reason though will be significant changes showing in derivative liabilities.
The third quarter 10Q will push PPS to new levels as the company will then have a full quarter of revenues from both hospitals and derivatives liabilities will be further decreased. With any luck dilution won't rear its ugly head then but we shall see.
I suspect shareholders might see developments in the spinoff(s) later this year since there is a real value to the company to conclude the intended spinoffs as soon as possible.
Of some concern is the total number of shares still possibly able to be converted by lenders (Sabby) so it could be cause for the PPS to continue to suffer in the next 12 - 18 months. I have not checked recently to determine how many shares can still be converted or the amount of warrants that can still be exercised by the lender who would of course convert into toxic debt. It really comes down to what the CEO and BOD adopt as a plan of action over the next couple of years, Do they actively work to increase share price by refinancing or paying down or off the toxic debt or do they focus on new acquisitions and let the shareholders bail them out of the toxic debt and/or until cash flow supports operations?
At least shareholders know there is no RS and no AS increase on the horizon.
Know what you own. Lots of risk moving forward still from a cash flow perspective but I see that diminishing rapidly as they seems to not have difficulty raising capital. I am a little concerned to see new financing still being convertible debt. Not sure if an warrants were exercised which ultimately could then become debt (toxic) but will continue watching what the company actually does as it moves forward in the coming months.
For me I continue holding my long position on 1 mil plus shares. Not chasing any buydown to reduce cost per share (that's just me) since I know MMs use the buydown process heavily for dilution and we have previously seen MMs use naked shorting to keep the PPS very low which signals to me they intend future dilution into events such as 10Q and positive news since this is what they have been doing. Have to keep an eye on the OS to see where that ends up.
Overall, I believe its a long road but the investment at these low prices is worth the risk when you consider risk/reward relative to the progress of the company.
Good stuff...
Thanks Baxy...
WRFX IS AHEAD OF ITS TIME, IT ALREADY HAS THIS........Microsoft inches closer to commercially-viable quantum computing
https://www.techrepublic.com/article/microsoft-inches-closer-to-commercially-viable-quantum-computing
>>> GREAT/MUST READ https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139609442
>>> GOOD READ READ https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139949586
Yep... By or before Friday me thinks...
RNVA=I SMELL GOOD NEWS COMING THIS WEEK.IT:S GOING TO BE HUGH.PENNYLAND THE NEXT STOP.ALL ABOARD.
Right you are George...
I predict a green wave past 20's by this Friday...
No downside dilution.. done here...
Strong Accumulation...
More Buys than sells each day...
Nope... But you might catch it in the 7's later today...
Lock up your shares...
Mine are on sale for $2.85
Most Excellent..!
NEWS
8:00 AM ET 7/10/18 | GlobeNewswire
Progressive Care Launches New Discharge(RX) Program to Improve Engagement Between Patients and Hospitals
MIAMI, July 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced the launch of its new proprietary patient engagement program, Discharge(RX) , designed to ensure that hospital patients are receiving the best transitional care while preserving vital hospital resources.
According to a 2017 study published in the Journal of the American Pharmacists Association, up to 26% of hospital readmissions are medication-related, creating a much-needed opportunity for a program to be created that is proactive towards patient engagement. Through Progressive Care's wholly owned subsidiaries, Discharge(RX) will provide hospitals with much needed support in preventing unnecessary and costly hospital readmissions. At no cost to the hospital or patient, the program will provide access to a PharmCo representative who will offer medication-related services throughout the patient's transitional process.
Through direct interaction between the patient and PharmCo, the company is able to understand the patient, their healthcare needs, follow-up plans and current drug regimen. After the consultation, recommendations may be made to optimize their prescription therapy through med synchronization and effective packaging options including the use of PharmCo's SmartPack adherence solution. The patient will be given a full overview of their prescriptions, uses and best methods for staying on track with doses.
Once a patient has received a prescription from their physician, PharmCo will obtain their prescription(s) directly from the hospital and fill them, alleviating the patient of those steps. After the prescription is filled, the patient will receive a home delivery of all prescribed medications on the same day as discharge, and in some of the most effective packaging solutions available. PharmCo's customer service staff will then monitor the patient's progress and keep them updated on their follow-ups with Primary Care and Specialist physicians. They will also be available to provide mitigation recommendations for medication-related adverse reactions to prevent short-term medication-related readmissions, as well as post-discharge medication reconciliation.
"Our new Discharge(RX) program hopes to provide even more patients with Progressive Care's adherence packaging, proactive engagement model and pharmacological expertise," said S. Parikh Mars, CEO of Progressive Care Inc. "The program's offering also stands to benefit hospitals, helping them to gain more control over readmission risk and improve transitional care outcomes, while also providing significant savings toward preventable adherence-related healthcare spending."
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
Catch up John...
PPS .0720
GO RXMD GOLD..!
Lock up your shares...
Mine are on sale for $2.85
Most Excellent..!
NEWS
8:00 AM ET 7/10/18 | GlobeNewswire
Progressive Care Launches New Discharge(RX) Program to Improve Engagement Between Patients and Hospitals
MIAMI, July 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced the launch of its new proprietary patient engagement program, Discharge(RX) , designed to ensure that hospital patients are receiving the best transitional care while preserving vital hospital resources.
According to a 2017 study published in the Journal of the American Pharmacists Association, up to 26% of hospital readmissions are medication-related, creating a much-needed opportunity for a program to be created that is proactive towards patient engagement. Through Progressive Care's wholly owned subsidiaries, Discharge(RX) will provide hospitals with much needed support in preventing unnecessary and costly hospital readmissions. At no cost to the hospital or patient, the program will provide access to a PharmCo representative who will offer medication-related services throughout the patient's transitional process.
Through direct interaction between the patient and PharmCo, the company is able to understand the patient, their healthcare needs, follow-up plans and current drug regimen. After the consultation, recommendations may be made to optimize their prescription therapy through med synchronization and effective packaging options including the use of PharmCo's SmartPack adherence solution. The patient will be given a full overview of their prescriptions, uses and best methods for staying on track with doses.
Once a patient has received a prescription from their physician, PharmCo will obtain their prescription(s) directly from the hospital and fill them, alleviating the patient of those steps. After the prescription is filled, the patient will receive a home delivery of all prescribed medications on the same day as discharge, and in some of the most effective packaging solutions available. PharmCo's customer service staff will then monitor the patient's progress and keep them updated on their follow-ups with Primary Care and Specialist physicians. They will also be available to provide mitigation recommendations for medication-related adverse reactions to prevent short-term medication-related readmissions, as well as post-discharge medication reconciliation.
"Our new Discharge(RX) program hopes to provide even more patients with Progressive Care's adherence packaging, proactive engagement model and pharmacological expertise," said S. Parikh Mars, CEO of Progressive Care Inc. "The program's offering also stands to benefit hospitals, helping them to gain more control over readmission risk and improve transitional care outcomes, while also providing significant savings toward preventable adherence-related healthcare spending."
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
Most Excellent..!
NEWS
8:00 AM ET 7/10/18 | GlobeNewswire
Progressive Care Launches New Discharge(RX) Program to Improve Engagement Between Patients and Hospitals
MIAMI, July 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced the launch of its new proprietary patient engagement program, Discharge(RX) , designed to ensure that hospital patients are receiving the best transitional care while preserving vital hospital resources.
According to a 2017 study published in the Journal of the American Pharmacists Association, up to 26% of hospital readmissions are medication-related, creating a much-needed opportunity for a program to be created that is proactive towards patient engagement. Through Progressive Care's wholly owned subsidiaries, Discharge(RX) will provide hospitals with much needed support in preventing unnecessary and costly hospital readmissions. At no cost to the hospital or patient, the program will provide access to a PharmCo representative who will offer medication-related services throughout the patient's transitional process.
Through direct interaction between the patient and PharmCo, the company is able to understand the patient, their healthcare needs, follow-up plans and current drug regimen. After the consultation, recommendations may be made to optimize their prescription therapy through med synchronization and effective packaging options including the use of PharmCo's SmartPack adherence solution. The patient will be given a full overview of their prescriptions, uses and best methods for staying on track with doses.
Once a patient has received a prescription from their physician, PharmCo will obtain their prescription(s) directly from the hospital and fill them, alleviating the patient of those steps. After the prescription is filled, the patient will receive a home delivery of all prescribed medications on the same day as discharge, and in some of the most effective packaging solutions available. PharmCo's customer service staff will then monitor the patient's progress and keep them updated on their follow-ups with Primary Care and Specialist physicians. They will also be available to provide mitigation recommendations for medication-related adverse reactions to prevent short-term medication-related readmissions, as well as post-discharge medication reconciliation.
"Our new Discharge(RX) program hopes to provide even more patients with Progressive Care's adherence packaging, proactive engagement model and pharmacological expertise," said S. Parikh Mars, CEO of Progressive Care Inc. "The program's offering also stands to benefit hospitals, helping them to gain more control over readmission risk and improve transitional care outcomes, while also providing significant savings toward preventable adherence-related healthcare spending."
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
Thank you Jerry...
$ RNVA. Yes i enjoy reading post when i see a person is sticking to the fact to the best of what they have seen and read which i see the understanding of how things work with the Big Board Stocks and thats what RNVA was up until October of last year and this CEO and directors still deal with RNVA as a Big Board stock and not a pinky. If it was a Stinky we sure wouldnt need 5 Directors and a Pinky CEO wouldnt listen to a Director if it had (1) because 98% of Stinkys dont want the truth known and they to busy trying to sell more shares. Q2 on August 15th should really help turn things around IMO so i will be adding all i can between now and then and starting again first thing in the morning. https://investorshub.advfn.com/uimage/uploads/2018/7/5/zyirhRNVA_Jamestown_hospital.jpg
GO > $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ RNVA
Right again Jerry...
$ RNVA. It wouldnt as you know but i will say that i just finished reading most all of your RNVA post all the way to your first RNVA post and your the only one that i,ve seen that really seems to understand and just post the facts as you know them and stayed in touch with a director of RNVA which like you i think is a very good ideal. As you know there has been no R/S Approved for the future because there has only been a Proposal of one that was never voted on and before they could ever do a R/S it would have to be voted on & Approved, but here it is in the Companys words clearly and not mine. What is in red was just a proposal that the directors desided aganst voting on and the Green was voted on and approved so the talk of a R/S is a waste of time unless the Company brings it up again and only then could it get voted on Period as most know for fact.
RENNOVA HEALTH WITHDRAWS PROPOSAL FOR A REVERSE STOCK SPLIT AT UPCOMING SHAREHOLDERS MEETING AND URGES SHAREHOLDERS TO VOTE "FOR" AND APPROVE THE REMAINING PROPOSALS
May 04, 2018
WEST PALM BEACH, Fla., May 04, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, today announces that the Board of Directors is withdrawing the request to approve a reverse stock split at its Special Meeting of Stockholders on May 9, 2018 at 11:00 a.m. Eastern time at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401.
“Following communication with our shareholders and our intention not to complete a reverse split of our common shares in the immediate future it was decided to remove the request to approve this action at the discretion of the Board as was described in our proxy statement” stated Seamus Lagan, President and Chief Executive Officer of Rennova, adding “Stockholder approval of the proposed increase in authorized common shares is both necessary and critical for the company going forward and it is our hope that our shareholders recognize this necessity and vote “for” and approve the remaining proposals now that the reverse split proposal has been removed. Without approval of the remaining proposals our plans to increase shareholder value going forward will be severely restricted”
The Rennova Health, Inc. Board of Directors unanimously recommends that shareholders vote in favor of the following proposals at the upcoming special meeting:
To approve an amendment to our certificate of incorporation, as amended, to increase the number of authorized shares of our common stock from 500,000,000 to 3,000,000,000 shares;
To approve the Company’s new 2018 Incentive Award Plan; and
To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of the proposals to increase the authorized common stock and approve the 2018 Incentive Award Plan.
Starting to see more green days for MMEG...
Perhaps impending news has leaked...
We shall see...
I believe we get to or through 10 by this Friday my friend...
8'S CLOSE!!! HOW SWEET!!!!!!!
I believe we get to or through 10 by this Friday my friend...
8'S CLOSE!!! HOW SWEET!!!!!!!
Looking awesome Baxy...
VERY VERY BIG!!!!! 110M ON THE BID AS WELL!!!
TOMORROW WILL BE FUN!!!!
100% Agree Stocked...
I believe it starts up again this week...
Seeing the price in the.05's was pathetic. Happy to see this 10% increase. can't wait to see the 250% plus increase! RXMD will shine again, just a matter of time:).
Something BIG is brewing here...
MASSIVE BID GROWING!!! ABOUT 90M ON THE BID!!!!
NEAR TAKE OFF!!
Right you are my friend...
.063 .065 wow see a run coming...
Right Gedi...
Feels like some good news this week...
HaHa...looks that way. Perhaps News tomorrow has leaked...
Yep...
I would say some big news is pending sometime this week...
Back to the Green Waves for RXMD...
Haha, I go away from the computer for ten minutes and pow! We are up 10% with one buy? What's up! Are people finally coming to their senses
Right you are Mclark...
They didn’t R/S they increased the outstanding shares but look at the authorized shares has not changed right? Because those new shares were bought by institutional investors with big money, even with 3 billion OS and 100 mil in rev the PPS should be .03, right now we have just over 1 bil OS. This got driven down by us, not you or me in particular but the OTC traders who dumped it or who didn’t understand what was going on. Once it hit a certain point everyone bailed. Now we have a whole new heard of investors accumulating these shares and when we break that 006 you will see a lot of people coming back. Q2 may be the first profitable qtr in the companies history. I talk to Sebastian on the board of directors, they know what’s going on trust me. They are well aware of the share price and I can tell you they themselves own this stock at a much higher price
The OS should be nearly gone soon...
Expect something Bid for RNVA by or before this Friday...
Except we don’t have 3B shares we have just over 1.1 B they approved a 2.5B increase but didn’t issue all of them. On top of that the authorized shares never increased because those new shares went to institutional investors not us
One billion shares traded per week and that OS should be taken out pretty soon... Perhaps by the end of this week..?
Right... .09 coming to RNVA soon enough...
With this high volume of shares traded daily, I would think the OS has significantly decreased over the past month or so...
Awesome DD there Jerry...
$ RNVA. Here is where CEO Seamus Lagan posts at and he is looking forward to Q2 with good reason as the month of June with all that back pay from Medicare & Medicaid will show on Q2 and he was having to cover that out of his pockets so if I were him I would be glad also.
I look forward to getting the 2nd quarter out. We will see Jamestown revenue for June. We should be able to reduce our bad debt provision that hit sales revenue in 1st quarter. It looks like the derivative liability will reduce by a massive number. Should show lot of progress.
— Seamus Lagan (@seamuslaganRH) June 19, 2018
Beautiful..!
You're quite generous to your family for Christmas my friend...
$ RNVA. Your right and I knew you would by doing more DD on it because there is nothing not to like once you see how they going to make those 2 hospitals profitable and I think you mentioned the Solutions part and the CFO yesterday and thats where it will all come from and why the CFO was promoted to CFO and getting the RNVA shares now as a bonus to her pay and to keep her there. She got the CEO the back pay back to June the 1st so fast from Medicare & Medicaid which was a ton of Money that the CEO was having to cover and my Family are tickled to death because they work that field and I am buying each 1 a Million shares each of RNVA as a Christmas Present instead of giving Cash this year and they know more about the hospital operations than I do but I know more about Buying Businesses as I,ve bought several through the years and been in stocks big time for over 30 years now and own many large Caps also.
Quote:
“Completing this acquisition which includes ownership of a nearby physicians practice and properly integrating and managing them to being cash flow positive and profitable is a key first step,” said Lagan. “If we can do that in the next three to six months and get to where we don’t need additional capital to cover overheads we can possibly exit 2018 looking for our next acquisition.”
https://investorshub.advfn.com/uimage/uploads/2018/7/5/ixotpRNVA_South_fork_hospital.jpg
https://investorshub.advfn.com/uimage/uploads/2018/7/5/zyirhRNVA_Jamestown_hospital.jpg
GO > $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ RNVA